1. Home
  2. CNDT vs CGEN Comparison

CNDT vs CGEN Comparison

Compare CNDT & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conduent Incorporated

CNDT

Conduent Incorporated

HOLD

Current Price

$1.46

Market Cap

201.6M

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.16

Market Cap

191.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNDT
CGEN
Founded
2016
1993
Country
United States
Israel
Employees
51000
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
201.6M
191.1M
IPO Year
2016
2001

Fundamental Metrics

Financial Performance
Metric
CNDT
CGEN
Price
$1.46
$2.16
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
1.2M
395.6K
Earning Date
05-11-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,042,000,000.00
N/A
Revenue This Year
$2.01
N/A
Revenue Next Year
$4.06
$75.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$1.30
52 Week High
$2.98
$3.24

Technical Indicators

Market Signals
Indicator
CNDT
CGEN
Relative Strength Index (RSI) 50.88 46.14
Support Level $1.32 $1.48
Resistance Level $1.60 $2.35
Average True Range (ATR) 0.09 0.08
MACD 0.00 0.03
Stochastic Oscillator 71.23 87.23

Price Performance

Historical Comparison
CNDT
CGEN

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation, as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments, namely Commercial Industries, which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas, of which the majority of revenue is generated in the United States.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: